Journal
Pediatric Rheumatology
Publication Date
12-30-2024
Volume
22
Issue
1
First Page
112
Document Type
Open Access Publication
DOI
10.1186/s12969-024-01046-3
Rights and Permissions
Balay-Dustrude, E., Fennell, J., Baszis, K. et al. Approaches and outcomes of adalimumab discontinuation in patients with well-controlled inflammatory arthritis: a systematic search and review. Pediatr Rheumatol 22, 112 (2024). https://doi.org/10.1186/s12969-024-01046-3 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Balay-Dustrude, Erin; Fennell, Jessica; Baszis, Kevin; Goh, Y Ingrid; Horton, Daniel B; Lee, Tzielan; Rotman, Chloe; Sutton, Anna; Twilt, Marinka; Halyabar, Olha; and CARRA JIA Inactive Disease Workgroup, "Approaches and outcomes of adalimumab discontinuation in patients with well-controlled inflammatory arthritis: A systematic search and review." Pediatric Rheumatology. 22, 1. 112 (2024).
https://digitalcommons.wustl.edu/oa_4/6654
Additional Links
Supplemental material is available for this article at publisher site.
